BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7674685)

  • 1. Contemporary approaches in medical management of patients with stable coronary artery disease.
    Carbajal EV; Deedwania PC
    Med Clin North Am; 1995 Sep; 79(5):1063-84. PubMed ID: 7674685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trials and tribulations associated with angina and traditional therapeutic approaches.
    Deedwania PC; Carbajal EV; Bobba VR
    Clin Cardiol; 2007 Feb; 30(2 Suppl 1):I16-24. PubMed ID: 18373326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.
    Kones R
    Vasc Health Risk Manag; 2010 Sep; 6():749-74. PubMed ID: 20859545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antianginal medications and long-term outcomes after elective catheterization in patients with coronary artery disease.
    Shen L; Vavalle JP; Broderick S; Shaw LK; Douglas PS
    Clin Cardiol; 2016 Dec; 39(12):721-727. PubMed ID: 28026916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina.
    Deedwania PC; Carbajal EV
    Am J Med; 2011 Aug; 124(8):681-8. PubMed ID: 21787900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antianginal and antiadrenergic therapy in acute coronary syndrome].
    Raos V; Bergovec M
    Acta Med Croatica; 2004; 58(2):123-7. PubMed ID: 15208797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current treatment of hypertension in patients with coronary artery disease recommended by different guidelines.
    Aronow WS
    Expert Opin Pharmacother; 2016; 17(2):205-15. PubMed ID: 26373919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant use of nitrates, calcium channel blockers, and beta blockers for optimal antianginal therapy.
    Cohn PF
    Clin Cardiol; 1994 Aug; 17(8):415-21. PubMed ID: 7955587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-anginal drugs: Systematic review and clinical implications.
    Pavasini R; Camici PG; Crea F; Danchin N; Fox K; Manolis AJ; Marzilli M; Rosano GMC; Lopez-Sendon JL; Pinto F; Balla C; Ferrari R
    Int J Cardiol; 2019 May; 283():55-63. PubMed ID: 30538056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antianginal Agents for the Management of Stable Ischemic Heart Disease: A Review.
    Mody P; Sidhu MS; Brilakis ES; Sacco JD; Banerjee S; Boden WE
    Cardiol Rev; 2016; 24(4):177-89. PubMed ID: 26274534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of beta blockade in the treatment of myocardial ischemia.
    Deedwania PC; Carbajal EV
    Am J Cardiol; 1997 Nov; 80(9B):23J-28J. PubMed ID: 9375946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug treatment of stable angina pectoris in the elderly: defining the place of calcium channel antagonists.
    Kumar S; Hall RJ
    Drugs Aging; 2003; 20(11):805-15. PubMed ID: 12964887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination of anti-angina drugs].
    Silber S
    Z Kardiol; 1989; 78 Suppl 2():160-74; discussion 188-9. PubMed ID: 2573981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antianginal Therapy for Stable Ischemic Heart Disease: A Contemporary Review.
    Padala SK; Lavelle MP; Sidhu MS; Cabral KP; Morrone D; Boden WE; Toth PP
    J Cardiovasc Pharmacol Ther; 2017 Nov; 22(6):499-510. PubMed ID: 28361599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period.
    Freedman SB; Daxini BV; Noyce D; Kelly DT
    J Am Coll Cardiol; 1995 Feb; 25(2):349-55. PubMed ID: 7829787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy.
    Klein W; Mitrovic V; Neuss H; Schlepper M; Cocco G; Prager G; Fitscha P; Meisner W
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S50-2. PubMed ID: 16296710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choosing the most appropriate treatment for stable angina. Safety considerations.
    Asirvatham S; Sebastian C; Thadani U
    Drug Saf; 1998 Jul; 19(1):23-44. PubMed ID: 9673856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nitrates for the therapy of coronary artery disease patients in the years beyond 2000.
    Darius H
    J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 2():S15-20; discussion S29-31. PubMed ID: 10499556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative effect of anti-anginal drugs on myocardial ischemia in patient with effort angina: evaluation by ambulatory electrocardiographic monitoring].
    Suzuki Y
    Hokkaido Igaku Zasshi; 1991 Jul; 66(4):441-9. PubMed ID: 1680782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.